Market Cap 494.51M
Revenue (ttm) 30.91M
Net Income (ttm) -209.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -677.68%
Debt to Equity Ratio 1.33
Volume 1,837,800
Avg Vol 1,906,824
Day's Range N/A - N/A
Shares Out 87.84M
Stochastic %K 81%
Beta 0.43
Analysts Strong Sell
Price Target $16.38

Company Profile

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small mole...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 292 4200
Address:
117 Kendrick Street, Suite 500, Needham, United States
dl42
dl42 Apr. 4 at 6:09 PM
$VSTM we shall see
1 · Reply
dl42
dl42 Apr. 2 at 8:34 PM
$VSTM is this us after late breaker? I’d take a mkt cap of $5B!
0 · Reply
sweddle
sweddle Apr. 2 at 5:41 PM
2 · Reply
Csab6362
Csab6362 Apr. 2 at 3:56 PM
$VSTM Genfleet’s GFH375 (KRAS G12D) getting Breakthrough traction in China: NSCLC sure and mPDAC very likely to get breakthrough designation! So China is effectively de-risking the biology for free, while VSTM „owns“ the high-value US/EU markets (VS-7375 ex-China rights). And with PDAC a real multi-billion dollar opportunity would be unlocked - and Big Pharma attention + M&A pressure would rise fast! With ~$500–700M market cap vs. multi-billion potential, the asymmetry is obvious… This is no longer a “maybe works” story…
0 · Reply
Crivit
Crivit Apr. 2 at 3:15 PM
0 · Reply
PencilNeckGeek
PencilNeckGeek Apr. 2 at 2:45 PM
$VSTM Nice to see upward movement in consecutive days. Hopefully this holds
1 · Reply
sweddle
sweddle Apr. 2 at 1:20 PM
0 · Reply
CrozrX
CrozrX Apr. 2 at 12:54 PM
$VSTM https://news.futunn.com/hk/post/71020498?level=4&data_ticket=1764928720141104
0 · Reply
CrozrX
CrozrX Apr. 2 at 12:25 PM
$VSTM After BTD in 🫁 NSCLC, now GFH375 gets BTD in PDAC by CDE 🇨🇳!
0 · Reply
Harvo
Harvo Apr. 2 at 11:07 AM
$VSTM https://www.cancernetwork.com/view/discussing-a-phase-2-defactinib-avutometinib-trial-in-diffuse-gastric-cancer
1 · Reply
Latest News on VSTM
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play

Mar 19, 2026, 3:32 PM EDT - 16 days ago

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play


Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript

Mar 4, 2026, 6:32 PM EST - 4 weeks ago

Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript


Verastem Oncology to Present at Upcoming Investor Conferences

Nov 5, 2025, 7:30 AM EST - 5 months ago

Verastem Oncology to Present at Upcoming Investor Conferences


Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 10:16 AM EST - 5 months ago

Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript


Verastem, Inc. (VSTM) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 8:55 PM EDT - 8 months ago

Verastem, Inc. (VSTM) Q2 2025 Earnings Call Transcript


Verastem: The Market Is Ignoring The Progress

Jul 16, 2025, 8:22 AM EDT - 9 months ago

Verastem: The Market Is Ignoring The Progress


U.S. FDA approves Verastem's cancer therapy

May 8, 2025, 12:23 PM EDT - 11 months ago

U.S. FDA approves Verastem's cancer therapy


Verastem Oncology Announces $75 million Private Placement

Apr 25, 2025, 9:00 AM EDT - 1 year ago

Verastem Oncology Announces $75 million Private Placement


Verastem: Planning The PDUFA Run-Up

Jan 3, 2025, 11:56 AM EST - 1 year ago

Verastem: Planning The PDUFA Run-Up


Verastem: BLA Acceptance Puts Key Goals In Sight

Jan 2, 2025, 11:39 AM EST - 1 year ago

Verastem: BLA Acceptance Puts Key Goals In Sight


dl42
dl42 Apr. 4 at 6:09 PM
$VSTM we shall see
1 · Reply
dl42
dl42 Apr. 2 at 8:34 PM
$VSTM is this us after late breaker? I’d take a mkt cap of $5B!
0 · Reply
sweddle
sweddle Apr. 2 at 5:41 PM
2 · Reply
Csab6362
Csab6362 Apr. 2 at 3:56 PM
$VSTM Genfleet’s GFH375 (KRAS G12D) getting Breakthrough traction in China: NSCLC sure and mPDAC very likely to get breakthrough designation! So China is effectively de-risking the biology for free, while VSTM „owns“ the high-value US/EU markets (VS-7375 ex-China rights). And with PDAC a real multi-billion dollar opportunity would be unlocked - and Big Pharma attention + M&A pressure would rise fast! With ~$500–700M market cap vs. multi-billion potential, the asymmetry is obvious… This is no longer a “maybe works” story…
0 · Reply
Crivit
Crivit Apr. 2 at 3:15 PM
0 · Reply
PencilNeckGeek
PencilNeckGeek Apr. 2 at 2:45 PM
$VSTM Nice to see upward movement in consecutive days. Hopefully this holds
1 · Reply
sweddle
sweddle Apr. 2 at 1:20 PM
0 · Reply
CrozrX
CrozrX Apr. 2 at 12:54 PM
$VSTM https://news.futunn.com/hk/post/71020498?level=4&data_ticket=1764928720141104
0 · Reply
CrozrX
CrozrX Apr. 2 at 12:25 PM
$VSTM After BTD in 🫁 NSCLC, now GFH375 gets BTD in PDAC by CDE 🇨🇳!
0 · Reply
Harvo
Harvo Apr. 2 at 11:07 AM
$VSTM https://www.cancernetwork.com/view/discussing-a-phase-2-defactinib-avutometinib-trial-in-diffuse-gastric-cancer
1 · Reply
bobbybottleserviz
bobbybottleserviz Apr. 1 at 11:52 PM
$VSTM its time
0 · Reply
dl42
dl42 Apr. 1 at 8:55 PM
$VSTM my wish is this builds to ~$8 by 4/17 and the late breaker sends it to $16+. There was an example 3 or 4 years ago, I can’t remember specifics some of the other longs can probaby fill in the gap. AH’s they released data and SP went from ~$10 to over $17. Unfortunately they released additional data the next morning that was misinterpreted and was the start of driving the stock down to $4-5.
0 · Reply
Stoltz13
Stoltz13 Apr. 1 at 8:04 PM
$VSTM when this gets momentum it flies. It could be a fast ride over $10 again and $20 isn't unrealistic with a bit of catalyst.
0 · Reply
Sdcharger
Sdcharger Apr. 1 at 4:50 PM
$VSTM This stock sure acts heavy - like someone knows a deal is coming soon.
1 · Reply
Marketismanipulated2
Marketismanipulated2 Apr. 1 at 4:02 PM
$VSTM THIS is the fucking reason why shorting needs to be banned! Why do people who don't collectively own a single fucking share between them dictate price of a stock? It's a practice that destroys great companies and jobs and steals hard earned money from people who ACTUALLY buy and own the stock. Shorts serve as much usefulness to the market and shareholders as cancer cells do to the human body and ticks do to a dog. All 3 examples are parasites that need eradicated. Criminal indeed.
0 · Reply
SagehenNed
SagehenNed Apr. 1 at 3:56 PM
$VSTM I guess two up days in a row was too much to ask. Meanwhile the XBI marches on.
0 · Reply
Alt_Fuel
Alt_Fuel Apr. 1 at 11:07 AM
$VSTM $ANL $ELTX $ERAS $RVMD Verastem making Presentations - April 10 to 13, 2026 related to the VSTM collaboration with GenFleet Therapeutics ...
1 · Reply
Alt_Fuel
Alt_Fuel Mar. 31 at 8:13 PM
$VSTM Green Volume Bars - 5 Minute Chart ...
0 · Reply
SagehenNed
SagehenNed Mar. 31 at 7:23 PM
$VSTM Classic VSTM selling off right on schedule. It always gives up at least 5% of its gains.
1 · Reply
sweddle
sweddle Mar. 31 at 7:03 PM
$VSTM @SagehenNed do the thing.
2 · Reply
Stoltz13
Stoltz13 Mar. 31 at 6:41 PM
$VSTM stomp the accelerator!
0 · Reply
PencilNeckGeek
PencilNeckGeek Mar. 31 at 3:27 PM
$VSTM What time will the 5% drop happen?
3 · Reply